1. Systematic review of health-related quality of life (HRQoL) issues associated with gastric cancer: capturing cross-cultural differences

   • Alison Rowsell
   • Samantha C. Sodergren
   • Mitsumi Terada

   Review Article Open access 11 June 2022 Pages: 665 - 677

   

2. Tumorigenic mechanisms of estrogen and Helicobacter pylori cytotoxin-associated gene A in estrogen receptor α-positive diffuse-type gastric adenocarcinoma

   • Seungkyung Kang
   • Miree Park
   • Soo-Jeong Cho

   Original Article 07 April 2022 Pages: 678 - 696

   

3. Clinicopathologic and genomic characteristics of mucinous gastric adenocarcinoma

   • Jae Eun Lee
   • Yoon Young Choi
   • Jae-Ho Cheong

   Original Article 09 May 2022 Pages: 697 - 711

   

4. Removal of small extracellular vesicles inhibits the progression of peritoneal dissemination in gastric cancer

   • Jun Shibamoto
   • Tomohiro Arita
   • Eigo Otsuji

   Original Article 04 April 2022 Pages: 712 - 725

   

5. Ubiquitination of ADRα1d/SerpinA1 complex stimulates hypoxia to induce gastric tumorigenesis with a combination of Helicobacter pylori and chronic stress through IL-1α

   • Faisal Aziz
   • Xiang Li
   • Zigang Dong

   Original Article 07 May 2022 Pages: 726 - 740

   

6. Choice of PD-L1 immunohistochemistry assay influences clinical eligibility for gastric cancer immunotherapy

   • Joe Yeong
   • Huey Yew Jeffrey Lum
   • Raghav Sundar

   Original Article Open access 04 June 2022 Pages: 741 - 750

   

7. Deep learning for automatic diagnosis of gastric dysplasia using whole-slide histopathology images in endoscopic specimens

   • Zhongyue Shi
   • Chuang Zhu
   • Mulan Jin

   Original Article 08 April 2022 Pages: 751 - 760

   

8. A comparative study of demarcation line diagnostic performance between non-magnifying observation with white light and non-magnifying observation with narrow-band light for early gastric cancer

   • Toshiki Kojima
   • Kenshi Yao
   • Akinori Iwashita

   Original Article 06 May 2022 Pages: 761 - 769

   

9. Evaluation of clinical validity of an S-1 dosage formula based on renal function using data of the SPIRITS and the G-SOX trials

   • Eisuke Booka
   • Chiyo K. Imamura
   • Narikazu Boku

   Original Article 31 March 2022 Pages: 770 - 782

   

10. A randomized phase III study of fractionated docetaxel, oxaliplatin, capecitabine (low-tox) vs epirubicin, oxaliplatin and capecitabine (eox) in patients with locally advanced unresectable or metastatic gastric cancer: the lega trial

    • Gerardo Rosati
    • Chiara Alessandra Cella
    • Roberto Labianca

    Original Article 30 March 2022 Pages: 783 - 793

    

11. Association between HER2 heterogeneity and clinical outcomes of HER2-positive gastric cancer patients treated with trastuzumab

    • Kyunghye Bang
    • Jaekyung Cheon
    • Yoon-Koo Kang

    Original Article 07 May 2022 Pages: 794 - 803

    

12. Clinical advantage of standardized robotic total gastrectomy for gastric cancer: a single-center retrospective cohort study using propensity-score matching analysis

    • Susumu Shibasaki
    • Masaya Nakauchi
    • Koichi Suda

    Original Article 17 March 2022 Pages: 804 - 816

    

13. Safety assessment of robotic gastrectomy and analysis of surgical learning process: a multicenter cohort study

    • Norihiro Shimoike
    • Tatsuto Nishigori
    • on behalf of Kyoto Esophageal and Gastric Surgery Study Group

    Original Article 13 April 2022 Pages: 817 - 826

    

14. Application value of overlap guiding tube (OGT) in assisting overlap esophagojejunostomy during laparoscopic total gastrectomy for gastric/gastroesophageal junction (G/GEJ) tumors

    • Chen Xinhua
    • Lin Tian
    • Yu Jiang

    Original Article Open access 23 April 2022 Pages: 827 - 836